ResMed Inc. held its annual meeting of stockholders on November 19, 2025. Shareholders approved an amendment and restatement of the ResMed Inc. 2009 Incentive Award Plan, which increases the number of shares reserved for issuance, eliminates the fixed term of the plan, and authorizes the grant of incentive stock options. An amendment and restatement of the ResMed Inc. 2018 Employee Stock Purchase Plan was also approved, increasing the number of shares available under the plan and removing the fixed term.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-289878), on November 20, 2025, and is solely responsible for the information contained therein.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.